INVESTMENT LETTER AND SUBSCRIPTION AGREEMENTInvestment Letter and Subscription Agreement • April 17th, 2006 • Dotronix Inc • Miscellaneous manufacturing industries • Minnesota
This Agreement shall constitute the irrevocable offer of the Undersigned to acquire, subject to the terms set forth in this Agreement, 492,121 shares of the Common Stock of Dotronix, Inc., a Minnesota corporation (the “Company”), in exchange for the Undersigned’s interest in three homeopathic products as more particularly described in that certain Asset Purchase Agreement between the Undersigned and the Company dated April 11, 2006 (“the Asset Purchase Agreement”). On execution by both parties, this Agreement shall become a bilateral agreement binding on both the Undersigned and the Company. Each part of this Agreement must be completed by the Undersigned and, by execution below, the Undersigned acknowledges that it understands that the Company is relying on the accuracy and completeness hereof in complying with its obligations under applicable securities laws.
INVESTMENT LETTER AND SUBSCRIPTION AGREEMENTInvestment Letter and Subscription Agreement • April 17th, 2006 • Dotronix Inc • Miscellaneous manufacturing industries
This Agreement shall constitute the irrevocable offer of the undersigned to purchase, subject to the terms set forth in this Agreement, 85,000 shares of the Common Stock of Dotronix, Inc., a Minnesota corporation (the “Company”), at a purchase price of $0.125 per share. On execution by both parties, this Agreement shall become a bilateral agreement binding on both the undersigned and the Company. Each part of this Agreement must be completed by the undersigned and, by execution below, the undersigned acknowledges that it understands that the Company is relying on the accuracy and completeness hereof in complying with its obligations under applicable securities laws.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • April 17th, 2006 • Dotronix Inc • Miscellaneous manufacturing industries • Minnesota
THIS ASSET PURCHASE AGREEMENT is made and entered into as of the 11th day of April, 2006 by and between DOTRONIX, INC., a Minnesota corporation (“Buyer”) and ACCELERATED DRUG DELIVERY, LLC, a Wisconsin limited liability company (“Seller”).
